Clinical Trial Update: Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing oral amantadine to gabapentin to attenuate responses to laryngoscopy and tracheal intubation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Effect of Laryngoscopy and Tracheal Intubation

Drugs mentioned

• Gabapentin (Gabapentin)
• amantadine (amantadine)

Snippet

Sponsor: Ghada Mohammed AboelFadl | Conditions: Effect of Laryngoscopy and Tracheal Intubation | Phase 2, Phase 3 | Status: COMPLETED